Channel NewsAsia |
FDA approves Mavyret for Hepatitis C
FDA.gov The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to ... FDA OKs new drug to treat all forms of hepatitis C FDA Approves New HCV Combo Pill, 8-Week Regimen |
from Health - Google News http://ift.tt/2fcS0Nj
EmoticonEmoticon